Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity
Dengue fever, an infectious disease that affects more than 100 million people every year, is a global health problem. Vaccination may be the most effective prevention strategy for the disease. However, the development of vaccines against dengue fever is complicated by the high risk of developing an...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2023-04-01
|
| Reeks: | Vaccines |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2076-393X/11/4/831 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|